Scilex Holding (SCLX) Return on Sales (2022 - 2026)

Scilex Holding (SCLX) recorded quarterly Return on Sales of 0.05% in Q1 2026, up 44.28% quarter-over-quarter from 0.1% in Q4 2025, and little changed on a YoY basis from 0.05% in Q1 2025.

Scilex Holding (SCLX) Return on Sales (2022 - 2026) Analysis & Trends

Scilex Holding's Return on Sales history runs 5 years deep, the most recent figure standing at 0.05% for Q1 2026.

  • In Q1 2026, Return on Sales changed 0.0% year-over-year to 0.05%; the TTM figure through Mar 2026 stood at 0.12% (down 10.0% YoY), while the FY2025 annual figure was 0.12%, down 11.0% from the prior year.
  • Return on Sales was 0.05% for Q1 2026 at Scilex Holding, up from 0.1% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.02% in Q3 2022 to a low of 0.24% in Q3 2025.
  • Historically, Return on Sales has averaged 0.04% across 5 years, with a median of 0.02% in 2022.
  • The sharpest annual moves came in 2024 and 2025: Return on Sales increased 3 bps in 2024, then retreated 24 bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.02% in 2022, then retreated by 6 bps to 0.02% in 2023, then surged by 73 bps to 0.0% in 2024, then plunged by 2097 bps to 0.1% in 2025, then soared by 44 bps to 0.05% in 2026.
  • The last three Return on Sales figures came in at 0.05% (Q1 2026), 0.1% (Q4 2025), and 0.24% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn 0.00%
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn 0.00%
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn 0.00%
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn 0.00%
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn 0.00%
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn 0.00%
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn 0.00%
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn 0.00%
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn 0.00%
10 Scilex Holding 48.31 Mn -101.62 Mn 4.15 Mn -0.05%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.05%
Dec 31, 2025 -0.10%
Sep 30, 2025 -0.24%
Jun 30, 2025 -0.04%
Mar 31, 2025 -0.05%
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%
Jun 30, 2024 -0.02%
Mar 31, 2024 -0.02%
Dec 31, 2023 -0.02%
Sep 30, 2023 -0.04%
Jun 30, 2023 -0.02%
Mar 31, 2023 -0.03%
Dec 31, 2022 -0.02%
Sep 30, 2022 0.02%
Jun 30, 2022 -0.02%
Mar 31, 2022 -0.01%